메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
(Department of Social and Preventive Medicine Sungkyunkwan University School of Medicine Suwon Korea) (Biostatistics Collaboration Unit Department of Biomedical Systems Informatics Yonsei University Col) (Biostatistics Collaboration Unit Department of Biomedical Systems Informatics Yonsei University Col) (Department of Pediatrics Severance Children's Hospital Yonsei University College of Medicine Seoul) (Department of Pediatrics Severance Children's Hospital Yonsei University College of Medicine Seoul) (Department of Pediatrics Severance Children's Hospital Yonsei University College of Medicine Seoul) (Division of Infectious Diseases Department of Medicine Samsung Medical Center Sungkyunkwan Universi) (Artificial Intelligence and Big-Data Convergence Center Gil Medical Center Gachon University Colleg) (Department of Pediatrics Severance Children's Hospital Yonsei University College of Medicine Seoul)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.37 No.34
오류 신고하기

피인용 1

검색

    초록·키워드

    Background: This study aimed to investigate whether respiratory syncytial virus (RSV) and influenza virus (IFV) infections would occur in 2021–2022 as domestic nonpharmaceutical interventions (NPIs) are easing. Methods: Data were collected from the Korean Influenza and Respiratory Virus Monitoring System database. The weekly positivity rates of respiratory viruses and number of hospitalizations for acute respiratory infections were evaluated (January 2016–2022). The period from February 2020 to January 2022 was considered the NPI period. The autoregressive integrated moving average model and Poisson analysis were used for data analysis. Data from 14 countries/regions that reported positivity rates of RSV and IFV were also investigated. Results: Compared with the pre-NPI period, the positivity and hospitalization rates for IFV infection during 2021–2022 significantly decreased to 0.0% and 1.0%, respectively, at 0.0% and 1.2% of the predicted values, respectively. The RSV infection positivity rate in 2021–2022 was 1.8-fold higher than that in the pre-NPI period at 1.5-fold the predicted value. The hospitalization rate for RSV was 20.0% of that in the pre-NPI period at 17.6% of the predicted value. The re-emergence of RSV and IFV infections during 2020–2021 was observed in 13 and 4 countries, respectively. Conclusion: During 2021–2022, endemic transmission of the RSV, but not IFV, was observed in Korea.

    최근 본 자료 전체보기